Collectively, these results suggest that increased ketogenesis by HMGCS2-OE effectively improves the HFD-induced hepatosteatosis and associated abnormal glucose metabolism in mice, however, may not reverse liver fibrosis. The gene discussed is HMGCS2; the disease is Hepatic fibrosis.